Xtl Biopharmaceuticals (XTLB) Net Shares Issued and Repurchased (2013 - 2014)
Xtl Biopharmaceuticals (XTLB) posted quarterly Net Shares Issued and Repurchased of $230000.0 for Q1 2014, up 33.72% on a QoQ basis from $172000.0 in Q4 2013.
Xtl Biopharmaceuticals (XTLB) Net Shares Issued and Repurchased (2013 - 2014) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $230000.0 the latest figure, recorded in Q1 2014.
- Quarterly Net Shares Issued and Repurchased changed N/A year-over-year to $230000.0 in Q1 2014, while the trailing twelve-month figure through Dec 2014 was $230000.0 (changed N/A YoY) and the FY2015 annual result came in at $1.5 million, up 552.61% from the prior year.
- Net Shares Issued and Repurchased rose to $230000.0 in Q1 2014 per XTLB's latest filing, from $172000.0 in the prior quarter.
- Over the last five years, Net Shares Issued and Repurchased for XTLB reached as high as $230000.0 in Q1 2014 and fell as low as $111000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 230,000.00 |
| Mar 31, 2014 | 230,000.00 |
| Dec 31, 2013 | 172,000.00 |
| Dec 31, 2013 | 172,000.00 |
| Sep 30, 2013 | 111,000.00 |
| Sep 30, 2013 | 111,000.00 |